Similar Posts
Franco-Nevada Co. (TSE:FNV) Senior Officer Sells C$1,270,422.53 in Stock
Franco-Nevada Co. (TSE:FNV – Get Free Report) (NYSE:FNV) Senior Officer Sandip Rana sold 5,675 shares of the stock in a transaction on Thursday, March 20th. The stock was sold at an average price of C$223.86, for a total transaction of C$1,270,422.53. Source link
Trading Watch List 02.12.2025
Range bound action with few earning/news plays here and there. Sticking with earning/news plays. Follow me on X/Twitter for real time trading setups @szaman and on StockTwits @szaman. Watch us trade these stocks LIVE, in real-time. Click here to get started! Check out our watch list and game plan: If you want to learn how to…
Vantagepoint AI Market Outlook for December 30, 2024
Welcome to the Artificial Intelligence Outlook for Forex trading. VIDEO TRANSCRIPT Okay, hello everyone, welcome back. My name is Greg Firman, and this is the Vantage Point AI Market Outlook for the week of December 30, 2024. U.S. Dollar Index Now, as the final presentation for 2024, we’ll look at the major markets. Each week,…
Linkfest: 22 January, 2026
Some stuff I am reading today morning: Transcript of Canadian PM Mark Carney at Davos (WEF) Transcript of US President Trump’s speech at Davos (MSN) Globalism died in Davos (Jim Ferguson) EU Parliament halts US trade deal (MC) EU trade deal will be great for India (MC) BSE Smallcap Index hits 8 month low (Rediff)…
RioCan Real Estate
Sound bite for Twitter and StockTwits is: Dividend Growth REIT. Results of stock price testing is that the stock price is probably reasonable. Debt Ratios are probably fine, but the company does have a lot of debt. The Dividend Payout Ratios (DPR) are probably fine as REIT tend to have high payouts than other types…
PER – Percheron Therapeutics
nice run-up this morning (up at one stage 300%) on ann re granting of aust patent and write-up in this month's edition of "The Prostate" aust patent – granted on the use of ATL1101 as a therapeutic agent to treat prostate cancer Source link